ARVO to award young scientists

Article

A series of awards granted to scientists under the age of 45 has been announced by the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research (AFER) and Merck & Co, Inc.

A series of awards granted to scientists under the age of 45 has been announced by the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research (AFER) and Merck & Co, Inc.

The ARVO-AFER/Merck Innovative Ophthalmology Research Award (IORA) grants, totalling $70,000 per cycle, will be awarded biennially to young scientists of MD, PhD or equivalent level throughout the world who have made "innovative contributions to ophthalmology research". The awards are granted in the categories of glaucoma and back-of-eye diseases, and first and second place prizes will be awarded in each category. In addition to grant funding, award recipients will receive travel expenses and registration fees for the annual ARVO meeting.

The award, formerly run by Merck as the Chibret Award, has been granted to more than 50 scientists since its initiation in 1982. Submissions for the first ARVO-AFER/Merck IORA have now closed, and the winners will be announced at the ARVO 2009 annual meeting, to be held on May 3–7 in Fort Lauderdale, US. The application process for the 2011 award will begin in 2010.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.